Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.
暂无分享,去创建一个
I. Ellis | R. Blamey | A. Green | J. Robertson | R. Nicholson | H. Habashy | D. Powe | E. Rakha | J. Gee | M. Grainge | Andrew H. S. Lee | M. El-Sayed | A. Green
[1] E. Wilkinson,et al. Molecular and Morphologic Distinctions between Infiltrating Ductal and Lobular Carcinoma of the Breast , 2007, The breast journal.
[2] V. Beral,et al. Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. , 2006, The Lancet. Oncology.
[3] H. Kuerer,et al. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. , 2006, American journal of surgery.
[4] P. Chérel,et al. Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] J. Robertson,et al. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation , 2006, The Journal of pathology.
[6] K. Bland,et al. Optimal surgical treatment of invasive lobular carcinoma of the breast , 1997, Annals of Surgical Oncology.
[7] S. Singletary,et al. Role of conservation therapy for invasive lobular carcinoma of the breast , 2006, Annals of Surgical Oncology.
[8] M. Fernö,et al. Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial , 2005, Journal of Clinical Pathology.
[9] G. Ball,et al. High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses , 2005, International journal of cancer.
[10] I. Andrulis,et al. Invasive lobular carcinoma: to grade or not to grade , 2005, Modern Pathology.
[11] V. Cocquyt,et al. Lobular carcinoma in situ and invasive lobular cancer of the breast , 2005, Current opinion in obstetrics & gynecology.
[12] G. Hortobagyi,et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] I. Ellis,et al. The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.
[14] H. Carmalt,et al. Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. , 2004, Breast.
[15] K. Holli,et al. A Comparison of the Biological and Clinical Features of Invasive Lobular and Ductal Carcinomas of the Breast , 2004, Breast Cancer Research and Treatment.
[16] J. Thiery,et al. Wide metastatic spreading in infiltrating lobular carcinoma of the breast. , 2004, European journal of cancer.
[17] R. Rouzier,et al. The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. , 2004, European journal of cancer.
[18] S. Schnitt,et al. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy , 2004, Breast Cancer Research and Treatment.
[19] R. Elledge,et al. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome , 2004, Breast Cancer Research.
[20] Jane Fridlyand,et al. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. , 2003, Cancer research.
[21] A. Paumier,et al. [Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas]. , 2003, Journal de gynecologie, obstetrique et biologie de la reproduction.
[22] P. Blondeel,et al. Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[23] B. Anderson,et al. Trends in incidence rates of invasive lobular and ductal breast carcinoma. , 2003, JAMA.
[24] D. Coradini,et al. Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence , 2002, British Journal of Cancer.
[25] A. Cleton-Jansen. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? , 2001, Breast Cancer Research.
[26] L. Liberman,et al. Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT. , 2000, AJR. American journal of roentgenology.
[27] G. Colli,et al. [Natural history of breast cancer: lobular carcinoma versus ductal carcinoma in our experience]. , 1997, Annali italiani di chirurgia.
[28] H. Joensuu,et al. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. , 1997, British Journal of Cancer.
[29] A. Vincent-Salomon,et al. Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns , 1996, Cancer.
[30] M. Silverstein,et al. Infiltrating lobular carcinoma: Is it different from infiltrating duct carcinoma? , 1994, Cancer.
[31] R. Blamey,et al. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long‐term follow‐up , 1992, Histopathology.
[32] J. Lamovec,et al. Metastatic pattern of infiltrating lobular carcinoma of the breast: An autopsy study , 1991, Journal of surgical oncology.
[33] I. Ellis,et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. , 1991, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[34] A. Cuschieri,et al. Long‐term follow‐up of elderly patients with locoregional breast cancer treated with tamoxifen only , 1991, The British journal of surgery.
[35] I. Ellis,et al. Invasive lobular carcinomas of the breast--the prognosis of histopathological subtypes. , 1989, British Journal of Cancer.
[36] A. Howell,et al. Infiltrating lobular carcinoma of the breast: response to endocrine therapy and survival. , 1987, European journal of cancer & clinical oncology.
[37] T. Mate,et al. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma , 1986, Cancer.
[38] M. Dixon. Infiltrating lobular carcinoma of the breast , 1986 .
[39] J. Azzopardi,et al. Invasive lobular carcinoma of the breast: incidence and variants , 1979, Histopathology.
[40] Elisa T. Lee,et al. A Monte Carlo study of the power of some two-sample tests , 1975 .
[41] A. Huvos,et al. Infiltrating lobular carcinoma of the breast , 1973, Cancer.